{
  "id": 12151555,
  "title": "Stifel raises Ambiq Micro stock price target to $85 on edge AI potential",
  "url": "https://urgent.news/2026/10/05/stifel-raises-ambiq-micro-stock-price-target-to-85-on-edge-ai",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-05T12:40:52.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/analyst-ratings/stifel-raises-ambiq-micro-stock-price-target-to-85-on-edge-ai-potential-93CH-4932134"
  },
  "original_language": "en",
  "account": "Stifel has increased its price target for Ambiq Micro Inc (NYSE:AMBQ) stock to $85.00, up from the previous $75.00 rating. The firm maintains a Buy rating for Ambiq, citing the company's SPOT platform semiconductor technology as a key competitive advantage. This technology allows for higher compute performance at lower power levels compared to existing transistor technologies. Ambiq's stock has shown strong performance, up 129% over the past year and 139% year-to-date. However, InvestingPro analysis indicates the shares may be overvalued at current levels. Ambiq is well-positioned to benefit from the edge AI semiconductor solutions market, as the company transitions toward higher-margin non-China applications, with China accounting for only 14% of its second-quarter 2026 revenue. The firm expects a significant inflection point in the first half of 2026, fueled by the expansion of Ambiq's customer base across a wider range of applications. The launch of Ambiq's next-generation AI-focused Atomiq product platform could further accelerate growth at higher margins. Stifel projects double-digit revenue growth in 2026, with non-GAAP gross margins improving to 45.0% in 2025 from 31.5% in 2024. Although the company remains unprofitable with a net loss of $2.02 per share, revenue grew by 32% in the last twelve months to $97.87 million. Ambiq's second-quarter performance saw an impressive 89.7% revenue increase to $33.9 million, and the company raised its full-year sales outlook to approximately $135 million. Recent analyst actions include UBS raising its price target to $73 and BofA Securities increasing its target to $75, both citing strong demand growth in wearables and new applications in medical, industrial, and smart-home sectors. Despite these positive developments, both UBS and BofA Securities maintain their Neutral and Underperform ratings on Ambiq Micro stock.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}